Bedtime, shuteye time and electronic media: sleep displacement is a two-step process
Related Experiment Video
Updated: Mar 6, 2026

Establishing a Device for Sleep Deprivation in Mice
Published on: September 22, 2023
Liese Exelmans1, Jan Van den Bulck2
1School for Mass Communication Research, KU Leuven, Leuven, Belgium.
Abstract:
This study argues that going to bed may not be synonymous with going to sleep, and that this fragmentation of bedtime results in a two-step sleep displacement. We separated bedtime (i.e. going to bed) from shuteye time (i.e. attempting to go to sleep once in bed) and assessed the prevalence of electronic media use in both time slots. A convenience sample of 338 adults (aged 18-25 years, 67.6% women) participated in an online survey. Results indicated a gap of 39 min between bedtime and shuteye time, referred to as 'shuteye latency'. Respondents with a shuteye latency of, respectively, ≤30 min, ≤1 or >1 h, were 3.3, 6.1 and 9.3 times more likely to be rated as poor sleepers compared to those who went to sleep immediately after going to bed. Before bedtime, volume of electronic media use (17 h 55 min per week) was higher than non-media activities (14 h per week), whereas the opposite was true after bedtime (media = 3 h 41 min, non-media = 7 h 46 min). Shuteye latency was related exclusively to prebedtime media use. Findings confirmed the proposed fragmentation of bedtime. Sleep displacement should therefore be redefined as a two-step process, as respondents not only engage in the delay of bedtime, but also in the delay of shuteye time once in bed. Theoretical, methodological and practical implications are discussed.
Related Concept Videos
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...

